Fujii S - Search Results

1

Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.

Fujii S. Fujii S. Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Trends Immunol. 2008. PMID: 18372215 Review.

2

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

Fujii S, Shimizu K, Kronenberg M, Steinman RM. Fujii S, et al. Nat Immunol. 2002 Sep;3(9):867-74. doi: 10.1038/ni827. Epub 2002 Aug 5. Nat Immunol. 2002. PMID: 12154358

3

Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.

Fujii S, Shimizu K, Steinman RM, Dhodapkar MV. Fujii S, et al. J Immunol Methods. 2003 Jan 15;272(1-2):147-59. doi: 10.1016/s0022-1759(02)00497-0. J Immunol Methods. 2003. PMID: 12505720

4

Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential.

Fujii S, Shimizu K, Koji F, Kawano F. Fujii S, et al. J Leukoc Biol. 2003 Jan;73(1):82-90. doi: 10.1189/jlb.0602267. J Leukoc Biol. 2003. PMID: 12525565

5

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.

Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii S, Dhodapkar KM, Krasovsky J. Dhodapkar MV, et al. Among authors: fujii s. J Exp Med. 2003 Jun 16;197(12):1667-76. doi: 10.1084/jem.20021650. Epub 2003 Jun 9. J Exp Med. 2003. PMID: 12796469 Free PMC article.

6

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.

Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Fujii S, et al. J Exp Med. 2003 Jul 21;198(2):267-79. doi: 10.1084/jem.20030324. J Exp Med. 2003. PMID: 12874260 Free PMC article.

7

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.

Fujii S, Shimizu K, Klimek V, Geller MD, Nimer SD, Dhodapkar MV. Fujii S, et al. Br J Haematol. 2003 Aug;122(4):617-22. doi: 10.1046/j.1365-2141.2003.04465.x. Br J Haematol. 2003. PMID: 12899717

8

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.

Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. Fujii S, et al. J Exp Med. 2004 Jun 21;199(12):1607-18. doi: 10.1084/jem.20040317. Epub 2004 Jun 14. J Exp Med. 2004. PMID: 15197224 Free PMC article.

9

Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.

Seino K, Fujii S, Harada M, Motohashi S, Nakayama T, Fujisawa T, Taniguchi M. Seino K, et al. Among authors: fujii s. Springer Semin Immunopathol. 2005 Jun;27(1):65-74. doi: 10.1007/s00281-004-0194-y. Epub 2005 Jan 14. Springer Semin Immunopathol. 2005. PMID: 15650847 Review.

10

Application of natural killer T-cells to posttransplantation immunotherapy.

Fujii S. Fujii S. Int J Hematol. 2005 Jan;81(1):1-5. doi: 10.1007/BF02983991. Int J Hematol. 2005. PMID: 15717680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results